×
About 28,073 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  7,752 results

Hochuekkito exerts the anti-allergic effects via activating regulatory T cells in a mur...
https://doi.org/10.1007/s11418-023-01683-0
Journal of Natural Medicines; Tsuge A, Chiba S et. al.

Feb 4th, 2023 - Hochuekkito (HET) is a Kampo prescription, used for the clinical treatment of skin diseases such as atopic dermatitis (AD), in Japan. Oral administration of HET exerts anti-allergic effects in an experimental dermatitis mice model and in patients ...

Biologics for pediatric atopic dermatitis: A protocol of a systematic review and meta-a...
https://doi.org/10.1371/journal.pone.0271712
PloS One; Cao R, Lu J et. al.

Feb 4th, 2023 - Atopic dermatitis is a chronic pruritic inflammatory skin disease commonly occurring in children. The objective of this study is to evaluate the treatment of pediatric atopic dermatitis with biologics, as they have displayed immense promising resu...

Atopic Keratoconjunctivitis (AKC)
https://emedicine.medscape.com/article/1194480-print

Feb 3rd, 2023 - Background Atopic keratoconjunctivitis (AKC) is a relatively uncommon but potentially blinding ocular condition. In 1952, Hogan described this disease as a bilateral conjunctivitis occurring in 5 male patients with atopic dermatitis. Originally re...

Studies of Skin Microbes in Healthy People and in People With Skin Conditions
https://clinicaltrials.gov/ct2/show/NCT00605878

Feb 3rd, 2023 - Skin microbiota (bacteria, fungi, viruses, phage, archae) play a significant role in common dermatological conditions, such as atopic dermatitis/AD (eczema). Since culture-dependent methods are often biased assessments of microbial diversity, geno...

Multicenter prospective observational study of dupilumab-induced ocular events in atopi...
https://doi.org/10.1111/jdv.18932
Journal of the European Academy of Dermatology and Venere... Costedoat I, Wallaert M et. al.

Feb 3rd, 2023 - Although ocular adverse events are frequent in AD patients treated with dupilumab, their characterization remains limited due to a lack of prospective studies with a systematic ophthalmological examination. To examine the incidence, characteristic...

see more →

Guidelines  10 results

English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis...
https://doi.org/10.1111/1346-8138.16527
The Journal of Dermatology; Saeki H, Ohya Y et. al.

Aug 23rd, 2022 - This is the English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021. Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. In Japan, from the perspective o...

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.

Jun 25th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venere... Wollenberg A, Barbarot S et. al.

Apr 21st, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

see more →

Drugs  603 results see all →

Clinicaltrials.gov  1,106 results

Studies of Skin Microbes in Healthy People and in People With Skin Conditions
https://clinicaltrials.gov/ct2/show/NCT00605878

Feb 3rd, 2023 - Skin microbiota (bacteria, fungi, viruses, phage, archae) play a significant role in common dermatological conditions, such as atopic dermatitis/AD (eczema). Since culture-dependent methods are often biased assessments of microbial diversity, geno...

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT05018806

Feb 3rd, 2023 - This is a parallel, treatment, Phase 2, double-blind, 2-arm, placebo-controlled study with 2 staggered cohorts (2 arms in each cohort) to evaluate the efficacy and safety of rilzabrutinib in adult participants (aged at least 18 years) with moderat...

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT05656911

Feb 3rd, 2023 - Researchers are looking for a better way to treat atopic dermatitis (AD), an often long-lasting inflammation of the skin. Atopic dermatitis, also called eczema, is causing patches of skin to become swollen, red, cracked, and itchy. The immune syst...

A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT05601882

Feb 3rd, 2023 - Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment...

Clinic-Based Atopic Dermatitis Therapeutic Patient Education
https://clinicaltrials.gov/ct2/show/NCT04352270

Feb 2nd, 2023 - Patients will be recruited, stratified, and then randomly assigned into one of two intervention groups.The patient participants will be children anywhere on the spectrum of mild to severe AD and they will be stratified into four strata: a) Those w...

see more →

News  1,713 results

Commentary: A New Drug, and Pediatric Concerns, February 2023
https://www.mdedge.com/dermatology/article/260900/atopic-dermatitis/commentary-new-drug-and-pediatric-concerns-february
Steven R. Feldman, MD, PhD

Jan 27th, 2023 - Steven R. Feldman, MD, PhD I suspect lebrikizumab is going to be another excellent atopic dermatitis (AD) treatment option.

Circular patch on chest
https://www.mdedge.com/familymedicine/article/260649/dermatology/circular-patch-chest
MDedge Family Medicine;

Jan 26th, 2023 - A skin scraping and potassium hydroxide (KOH) prep confirmed the presence of branching hyphae, consistent with tinea corporis. The large size of this plaque could have easily made this diagnosis more difficult.

Age-related atopic dermatitis phenotypes evaluated in study
https://www.mdedge.com/dermatology/article/260705/atopic-dermatitis/age-related-atopic-dermatitis-phenotypes-evaluated
Doug Brunk

Jan 20th, 2023 - Pediatric patients with atopic dermatitis (AD) are more likely to experience symptoms at classical sites such as the knees and have more associated and severe signs of AD, while older adults tend to present with less flexural eczema and the fewest.

AAD unveils updated guidelines for topical AD treatment in adults
https://www.mdedge.com/dermatology/article/260624/atopic-dermatitis/aad-unveils-updated-guidelines-topical-ad-treatment
Doug Brunk

Jan 13th, 2023 - When it comes to treating atopic dermatitis (AD) in adults with topical therapies, new guidelines from the American Academy of Dermatology rate the existing evidence as “strong” for prescription moisturizers, topical calcineurin inhibitors, topica.

IL-13 Blocker Beats Atopic Dermatitis
https://www.medpagetoday.com/dermatology/atopy/102592

Jan 11th, 2023 - Lebrikizumab, an investigational interleukin (IL)-13 inhibitor seeking to join an increasingly crowded market for atopic dermatitis treatments, effectively reduced symptoms of the condition (a.k.a. eczema) when combined with topical corticosteroid...

see more →

Patient Education  45 results see all →